We are happy to inform you that the fifth Dutch site, the Haaglanden Medisch Centrum in Den Haag, could be opened for patient recruitment on 1st of February 2023. We wish the study team good luck!
https://www.safesspe.ch/wp-content/uploads/sites/5/2020/05/safesspe-logo-400x82px-300x62.png00mpelusohttps://www.safesspe.ch/wp-content/uploads/sites/5/2020/05/safesspe-logo-400x82px-300x62.pngmpeluso2023-02-02 09:03:002023-02-07 12:38:38A new site in the Netherlands, the Haaglanden Medisch Centrum in Den Haag, was initiated and started with patient recruiting.
We are pleased to inform you that the first trial participant was enrolled at the Hospital of Neuchâtel on 22nd of December 2022. Thank you for your great effort!
We are pleased to inform you that the first trial participant was enrolled at the Isala Klinieken in Zwolle (NL) on 29th of November 2022. Thank you for your great effort!
A new site in the Netherlands, the Haaglanden Medisch Centrum in Den Haag, was initiated and started with patient recruiting.
We are happy to inform you that the fifth Dutch site, the Haaglanden Medisch Centrum in Den Haag, could be opened for patient recruitment on 1st of February 2023. We wish the study team good luck!
We are pleased to inform you that the first trial participant was enrolled at the Hospital of Neuchâtel on 22nd of December 2022. Thank you for your great effort!
First patient enrolled in Zwolle!
We are pleased to inform you that the first trial participant was enrolled at the Isala Klinieken in Zwolle (NL) on 29th of November 2022. Thank you for your great effort!